Judith Klein-Seetharaman

Dr. Judith Klein-Seetharaman

1. School of Molecular Sciences, Arizona State University, Phoenix, AZ 85004, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2016 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
VKValerian E. Kagan
Valerian E. Kagan
GMGaowei Mao
Gaowei Mao
FQFeng Qu
Feng Qu
JAJose Pedro Friedmann Angeli
Jose Pedro Friedmann Angeli
SDSebastian Doll
Sebastian Doll
HBHülya Bayır
Hülya Bayır

5 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Alex MohrAlex Mohr
Alex Mohr
COCarmen P. Ortega-Santos
Carmen P. Ortega-Santos
CWCorrie Whisner
Corrie Whisner
Judith Klein-SeetharamanJudith Klein-Seetharaman
Judith Klein-Seetharaman
Paniz JasbiPaniz Jasbi
Paniz Jasbi
The field of multi-omics has witnessed unprecedented growth, converging multiple scientific disciplines and technological advances. This surge is evidenced by a more than doubling in multi-omics scientific publications within just two years (2022–2023) since its first referenced mention in 2002, as indexed by the National Library of Medicine. This emerging field has demonstrated its capability to provide comprehensive insights into complex biological systems, representing a transformative force in health diagnostics and therapeutic strategies. However, several challenges are evident when merging varied omics data sets and methodologies, interpreting vast data dimensions, streamlining longitudinal sampling and analysis, and addressing the ethical implications of managing sensitive health information. This review evaluates these challenges while spotlighting pivotal milestones: the development of targeted sampling methods, the use of artificial intelligence in formulating health indices, the integration of sophisticated n-of-1 statistical models such as digital twins, and the incorporation of blockchain technology for heightened data security. For multi-omics to truly revolutionize healthcare, it demands rigorous validation, tangible real-world applications, and smooth integration into existing healthcare infrastructures. It is imperative to address ethical dilemmas, paving the way for the realization of a future steered by omics-informed personalized medicine.

14 December 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
FVFilippo Veglia
Filippo Veglia
VTVladimir A. Tyurin
Vladimir A. Tyurin
DMDariush Mohammadyani
Dariush Mohammadyani
MBMaria Blasi
Maria Blasi
EDElizabeth K. Duperret
Elizabeth K. Duperret
DGDmitry Gabrilovich
Dmitry Gabrilovich
Cross-presentation is a critical function of dendritic cells (DCs) required for induction of antitumor immune responses and success of cancer immunotherapy. It is established that tumor-associated DCs are defective in their ability to cross-present antigens. However, the mechanisms driving these defects are still unknown. We find that impaired cross-presentation in DCs is largely associated with defect in trafficking of peptide–MHC class I (pMHC) complexes to the cell surface. DCs in tumor-bearing hosts accumulate lipid bodies (LB) containing electrophilic oxidatively truncated (ox-tr) lipids. These ox-tr-LB, but not LB present in control DCs, covalently bind to chaperone heat shock protein 70. This interaction prevents the translocation of pMHC to cell surface by causing the accumulation of pMHC inside late endosomes/lysosomes. As a result, tumor-associated DCs are no longer able to stimulate adequate CD8 T cells responses. In conclusion, this study demonstrates a mechanism regulating cross-presentation in cancer and suggests potential therapeutic avenues.

1 September 2015 in Biophysical Journal
Verified
Journal Article
Closed access
JPJoan Planas-Iglesias
Joan Planas-Iglesias
HDHimal Dwarakanath
Himal Dwarakanath
DMDariush Mohammadyani
Dariush Mohammadyani
NYNaveena Yanamala
Naveena Yanamala
VKValerian E. Kagan
Valerian E. Kagan
Judith Klein-SeetharamanJudith Klein-Seetharaman
Judith Klein-Seetharaman

28 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
Alex MohrAlex Mohr
Alex Mohr
KSKaren L. Sweazea
Karen L. Sweazea
Devin A BowesDevin A Bowes
Devin A Bowes
PJPaniz Jasbi
Paniz Jasbi
CWCorrie Whisner
Corrie Whisner
Paul ArcieroPaul Arciero
Paul Arciero
The gut microbiome (GM) modulates body weight/composition and gastrointestinal functioning; therefore, approaches targeting resident gut microbes have attracted considerable interest. Intermittent fasting (IF) and protein pacing (P) regimens are effective in facilitating weight loss (WL) and enhancing body composition. However, the interrelationships between IF- and P-induced WL and the GM are unknown. The current randomized controlled study describes distinct fecal microbial and plasma metabolomic signatures between combined IF-P (n = 21) versus a heart-healthy, calorie-restricted (CR, n = 20) diet matched for overall energy intake in free-living human participants (women = 27; men = 14) with overweight/obesity for 8 weeks. Gut symptomatology improves and abundance of Christensenellaceae microbes and circulating cytokines and amino acid metabolites favoring fat oxidation increase with IF-P (p < 0.05), whereas metabolites associated with a longevity-related metabolic pathway increase with CR (p < 0.05). Differences indicate GM and metabolomic factors play a role in WL maintenance and body composition. This novel work provides insight into the GM and metabolomic profile of participants following an IF-P or CR diet and highlights important differences in microbial assembly associated with WL and body composition responsiveness. These data may inform future GM-focused precision nutrition recommendations using larger sample sizes of longer duration. Trial registration, March 6, 2020 (ClinicalTrials.gov as NCT04327141), based on a previous randomized intervention trial.

19 June 2013 in Bioinformatics
Verified
Journal Article
Open access
PDF file
MKMeghana Kshirsagar
Meghana Kshirsagar
JCJaime Carbonell
Jaime Carbonell
Judith Klein-SeetharamanJudith Klein-Seetharaman
Judith Klein-Seetharaman
Motivation: An important aspect of infectious disease research involves understanding the differences and commonalities in the infection mechanisms underlying various diseases. Systems biology-based approaches study infectious diseases by analyzing the interactions between the host species and the pathogen organisms. This work aims to combine the knowledge from experimental studies of host–pathogen interactions in several diseases to build stronger predictive models. Our approach is based on a formalism from machine learning called ‘multitask learning’, which considers the problem of building models across tasks that are related to each other. A ‘task’ in our scenario is the set of host–pathogen protein interactions involved in one disease. To integrate interactions from several tasks (i.e. diseases), our method exploits the similarity in the infection process across the diseases. In particular, we use the biological hypothesis that similar pathogens target the same critical biological processes in the host, in defining a common structure across the tasks. Results: Our current work on host–pathogen protein interaction prediction focuses on human as the host, and four bacterial species as pathogens. The multitask learning technique we develop uses a task-based regularization approach. We find that the resulting optimization problem is a difference of convex (DC) functions. To optimize, we implement a Convex–Concave procedure-based algorithm. We compare our integrative approach to baseline methods that build models on a single host–pathogen protein interaction dataset. Our results show that our approach outperforms the baselines on the training data. We further analyze the protein interaction predictions generated by the models, and find some interesting insights. Availability: The predictions and code are available at: http://www.cs.cmu.edu/∼mkshirsa/ismb2013_paper320.html Contact: j.klein-seetharaman@warwick.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.